Resources Repository
-
Online LearningVideo, Teaching Resource 2020Valuing Statistical Lives: Concepts, Current Practices, and Challenges
Many policies aim to improve longevity, decreasing the risk of death in each year, and …
Many policies aim to improve longevity, decreasing the risk of death in each year, and the value of these risk reductions often dominate the estimated benefits of risk regulations and other policies. This value is often expressed as the value per statistical life (VSL), a term that is widely misunderstood. It is not the value that the analyst, the government, or the individual places on saving an identified life with certainty. Instead, it reflects individuals’…
Global | Benefit-Cost Analysis | Policy/Regulation | Climate/Environment | Health/Medicine -
Online LearningPodcast, Teaching Resource 2018Choiceology with Katy Milkman
Through a series of ~30 minute podcasts sponsored by Charles Schwab, Katy Milkman a Wharton …
Through a series of ~30 minute podcasts sponsored by Charles Schwab, Katy Milkman a Wharton Professor asks “can we learn to make smarter choices?” Available for free through Apple’s iTunes, Google Podcasts or Spotify, Milkman explores lessons that have been learned from behavioral economics, sharing stories of irrational decision making--from historical blunders to everyday errors with the potential to impact the future. Season 1 of Choiceology included 7 podcasts hosted by author Dan Heath that…
Decision Psychology | Global | High School | College | Graduate | Doctoral | Professional | Critical Thinking/Analysis -
Resource PackPublication, Teaching Resource 2017Resource Pack: CEA Herpes Zoster Vaccine
This resource pack on the cost-effectiveness of herpes zoster vaccination was curated to support Dr. …
This resource pack on the cost-effectiveness of herpes zoster vaccination was curated to support Dr. Lisa Prosser's seminar on November 9, 2017 at the Center for Health Decision Science. Dr. Prosser discussed an economic evaluation of vaccination against herpes zoster. Herpes zoster—more commonly known as shingles—presents a major burden for older Americans but, until recently, the only available vaccine (Zoster Vaccine Live, ZVL) was relatively ineffective past 10 years. A recently approved vaccine–herpes zoster subunit…
Preferences/Values | Europe | Costing Methods | Health Outcomes | Mathematical Models | Cost-Effectiveness Analysis | Infectious Diseases | Clinical Care | Culture/Society | Health/Medicine | Science/Technology | North America